\
&
Contact us
\
&
Contact us
Published on | 1 year ago
ProgrammesAGRARIAN 1st Open Call aims to attract and engage SMEs/Universities/Research Centers/NGOs with expertise in developing innovative applications and services related to agriculture, which will be tested and validated within AGRARIAN framework.
This is a cascade call organised in the framework of a project funded by the EU’s Horizon Europe research and innovation program under Grant Agreement no. 101134128.
Proposals are expected to address innovative solutions/services, AI based applications and new IoTs, related to one of the three pilots (Livestock, Field Crops, and Viticulture).
The following types of Applications/Solutions (but not limited to) are expected to be funded:
The proposed Applications/Solutions should:
Total funding available: 400 000,00 € (8 Potential Projects / 50,000 € per entity)
Application deadline: 31 January 2025.
Please visit the dedicated website for more information and to apply for this call.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
